SARS-CoV-2 in cardiomyocytes

Código QR

SARS-CoV-2 in cardiomyocytes

Guardado en:

Detalles Bibliográficos
Autor principal:	Josef Finsterer
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	SARS-CoV-2 Covid-19 Heart Takotsubo Heart failure Infectious and parasitic diseases RC109-216
Acceso en línea:	https://doaj.org/article/f0f0a48d7e2449f3a92ac96e93ac3d48
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

SARS-CoV-2 seroprevalence rates of children seeking medical care in Louisiana during the state stay at home order
por: Monika L. Dietrich, et al.
Publicado: (2021)

Stillborn child with diffuse SARS-CoV-2 viral infection of multiple organs
por: Vsevolod A. Zinserling, et al.
Publicado: (2021)

Household transmission of SARS-CoV-2: a prospective observational study in Bosnia and Herzegovina, August–December 2020
por: Sanjin Musa, et al.
Publicado: (2021)

SARS-CoV-2 seroprevalence among 7950 healthcare workers in the Region of Southern Denmark
por: Sebastian von Huth, et al.
Publicado: (2021)

Limited and Short-Lasting Virus Neutralizing Titers Induced by Inactivated SARS-CoV-2 Vaccine
por: Taweewun Hunsawong, et al.
Publicado: (2021)

The effect of eye protection on SARS-CoV-2 transmission: a systematic review
por: Oyungerel Byambasuren, et al.
Publicado: (2021)

Seroprevalence of anti-SARS-CoV-2 antibodies and risk factors among healthy blood donors in Luanda, Angola
por: Cruz S. Sebastião, et al.
Publicado: (2021)

Models for COVID-19 Early Cardiac Pathology Following SARS-CoV-2 Infection
por: Maurice Fremont-Smith, et al.
Publicado: (2021)

Persistence of SARS-CoV-2 infection on personal protective equipment (PPE)
por: Elizabeth Córdoba-Lanús, et al.
Publicado: (2021)

Real-Time SARS-CoV-2 Genotyping by High-Throughput Multiplex PCR Reveals the Epidemiology of the Variants of Concern in Qatar
por: Mohammad R. Hasan, et al.
Publicado: (2021)

Performance of the T-SPOTⓇ.COVID test for detecting SARS-CoV-2-responsive T cells
por: Margaret Kruse, et al.
Publicado: (2021)

Estimates of global SARS-CoV-2 infection exposure, infection morbidity, and infection mortality rates in 2020
por: Houssein H. Ayoub, et al.
Publicado: (2021)

Potential recurrence of COVID-19 in a healthcare professional: SARS-CoV-2 genome sequencing confirms contagiousness after re-positivity
por: Ana M Correia, et al.
Publicado: (2021)

Performance and cost-effectiveness of a pooled testing strategy for SARS-CoV-2 using real-time polymerase chain reaction in Uganda
por: Naghib Bogere, et al.
Publicado: (2021)

Reactions and COVID-19 disease progression following SARS-CoV-2 monoclonal antibody infusion
por: Laurel Goldin, et al.
Publicado: (2021)

High seroprevalence of SARS-CoV-2 but low infection fatality ratio eight months after introduction in Nairobi, Kenya
por: Isaac Ngere, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 antibodies in the general population of Oman: results from four successive nationwide sero-epidemiological surveys
por: Seif Salem Al-Abri, et al.
Publicado: (2021)

Examining SARS-CoV-2 Interventions in Residential Colleges Using an Empirical Network
por: Hali L. Hambridge, et al.
Publicado: (2021)

The vaccination threshold for SARS-CoV-2 depends on the indoor setting and room ventilation
por: A. Mikszewski, et al.
Publicado: (2021)

Hypersensitivity reaction to hyaluronic acid dermal filler after the Pfizer vaccination against SARS-CoV-2
por: Demetris Savva, et al.
Publicado: (2021)

Pandemia SARS-CoV-2 y embarazo en el Hospital el Pino: un estudio descriptivo
por: Morales M.,Nereida, et al.
Publicado: (2020)

Utilisation of SARS-CoV-2 rapid antigen assays in screening asymptomatic hospital visitors: mitigating the risk in low-incidence settings
por: Liang En Wee, et al.
Publicado: (2022)

Common Laboratory Mice Are Susceptible to Infection with the SARS-CoV-2 Beta Variant
por: Ravi Kant, et al.
Publicado: (2021)

Mutations in emerging variant of concern lineages disrupt genomic sequencing of SARS-CoV-2 clinical specimens
por: Kevin S. Kuchinski, et al.
Publicado: (2022)

Development of a fully automated high throughput PCR for the detection of SARS-CoV-2: The need for speed
por: Florian J. Mayer, et al.
Publicado: (2020)

Evaluation of Panbio rapid antigen test for SARS‐CoV‐2 in symptomatic patients and their contacts: a multicenter study
por: Ireri Thirion-Romero, et al.
Publicado: (2021)

Study of perinatal transmission of SARS-CoV-2 in a Mexican public hospital
por: Adriana Ramírez-Rosas, et al.
Publicado: (2021)

SARS-CoV-2 rapid antigen testing in the healthcare sector: A clinical prediction model for identifying false negative results
por: Johannes Leiner, MD, et al.
Publicado: (2021)

Protective Immunity after Natural Infection with Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) – Kentucky, USA, 2020
por: Kevin B. Spicer, et al.
Publicado: (2022)

Can a Nasal/Oral/Ocular Spray Inactivate and Prevent SARS-CoV-2 infection? A hypothesis
por: Fuentes,Edgardo, et al.
Publicado: (2020)

Methodology for assessing herd immunity to the SARS-CoV-2 virus in the context of the COVID-19 pandemic
por: A. Yu. Popova, et al.
Publicado: (2021)

SARS-CoV-2 and Public Transport in Italy
por: Giuseppina Caggiano, et al.
Publicado: (2021)

Neutralizing antibody response to SARS-CoV-2 persists 9 months post symptom onset in mild and asymptomatic patients
por: Olivier Bylicki, et al.
Publicado: (2021)

SARS-CoV-2 Sequence Analysis during COVID-19 Case Surge, Liberia, 2021
por: Bode Shobayo, et al.
Publicado: (2021)

SARS-CoV-2 variants with T135I nucleocapsid mutations may affect antigen test performance
por: Ming-Jr Jian, et al.
Publicado: (2022)

Evaluation of the performance of 25 SARS-CoV-2 serological rapid diagnostic tests using a reference panel of plasma specimens at the Uganda Virus Research Institute
por: Tom Lutalo, et al.
Publicado: (2021)

In-Depth Longitudinal Comparison of Clinical Specimens to Detect SARS-CoV-2
por: Justine Defêche, et al.
Publicado: (2021)

SARS-CoV-2 B.1.1.7 Variant Infection in Malayan Tigers, Virginia, USA
por: Patrick K. Mitchell, et al.
Publicado: (2021)

Mouthwashes and Nasal Sprays as a Way to Prevent the Spread of SARS-CoV-2
por: Santos-López,Matías, et al.
Publicado: (2020)

SARS‐CoV‐2 neutralizing antibodies decline over one year and patients with severe COVID‐19 pneumonia display a unique cytokine profile
por: Vimvara Vacharathit, et al.
Publicado: (2021)